Antibody-dependent enhancement and COVID-19: Moving toward acquittal

Autor: Eric J. Yager
Rok vydání: 2020
Předmět:
0301 basic medicine
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
Acquittal
Immunology
Pneumonia
Viral
Antigen-Antibody Complex
medicine.disease_cause
Antibodies
Viral
Severe Acute Respiratory Syndrome
Enhancing Antibodies
Severity of Illness Index
03 medical and health sciences
Betacoronavirus
0302 clinical medicine
Pandemic
medicine
Antiviral antibodies
Immunology and Allergy
Humans
Immune Complex Diseases
Antibody-dependent enhancement
Pandemics
Letter to the Editor
COVID-19 Serotherapy
Coronavirus
Vaccines
biology
business.industry
SARS-CoV-2
Immunization
Passive
COVID-19
Virology
Antibody-Dependent Enhancement
Viral immunity
Immunity
Humoral
Receptors
Complement
030104 developmental biology
Immunoglobulin G
biology.protein
Antibody
business
Coronavirus Infections
030215 immunology
Zdroj: Clinical Immunology (Orlando, Fla.)
Clinical Immunology
ISSN: 1521-7035
Popis: Highlights • Immunoglobulins represent an effective therapeutic option for the treatment of COVID-19. • Experimental findings of ADE with related coronaviruses provoked theoretical concerns of enhancing antibodies with COVID-19. • Emerging experimental and clinical data alleviate concerns and indorse the safety of antibody-based therapies for COVID-19.
Databáze: OpenAIRE
Externí odkaz: